Coronavirus Disease-19: An interim evidence synthesis of the world association for infectious diseases and immunological disorders (Waidid)
journal contributionposted on 2023-05-21, 10:26 authored by Abu-Raya, B, Migliori, GB, O'Ryan, M, Edwards, K, Torres, A, Alffenaar, JW, Martson, AG, Centis, R, D'Ambrosio, L, Katie FlanaganKatie Flanagan, Hung, I, Lauretani, F, Leung, CC, Leuridan, E, Maertens, K, Maggio, MG, Nadel, S, Hens, N, Niesters, H, Osterhaus, A, Pontali, E, Rossato Silva, D, Omer, S, Spanevello, A, Sverzellati, N, Tan, T, Torres-Torreti, JP, Visca, D, Esposito, S
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
Publication titleFrontiers in Medicine
Department/SchoolTasmanian School of Medicine
PublisherFrontiers Media S.A.
Place of publicationSwitzerland
Rights statementCopyright 2020 The Author(s) Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/